Fri, Dec 19, 2014, 9:22 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • thirdmeinvestor thirdmeinvestor Jul 10, 2009 10:37 AM Flag

    CF opportunity sent me the following email. (VRTX) Ticker Alert for In Play

    10-Jul-09 09:28 ET

    Vertex Pharm: Management dinner highlights cystic fibrosis opportunity -
    Leerink Swann (33.39)

    Earlier this week, VRTX mgmt hosted an investor dinner, discussing the cystic
    fibrosis (CF) program. The co provided an overview of the Phase III program
    for VX-770 (potentiator) and VX-809 (corrector). Takeaways from the dinner
    included the expected growth in the CF mkt, the potential for VX-770 beyond
    the initially targeted G551D mutation population, and interesting in vitro
    data for VX-809 supporting the biological rationale of increased localization
    of the cystic fibrosis transport receptor (CFTR) protein to the cell surface
    and subsequent improvement in chloride ion transport.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
118.90+1.16(+0.99%)Dec 19 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.